# EDGAR Filing Document

**Accession Number:** 0001707925
**File Stem:** 0001757274-25-000004
**Filing Date:** 2025-12
**Character Count:** 9179
**Document Hash:** a71b08bd7d2046b1c5a52f46c6f37517
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001757274-25-000004.hdr.sgml**: 20251208

**ACCESSION NUMBER**: 0001757274-25-000004

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251208

**FILED AS OF DATE**: 20251208

**DATE AS OF CHANGE**: 20251208

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Lamba Sanjiv
- **CENTRAL INDEX KEY:** 0001757274

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38730
- **FILM NUMBER:** 251555904

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** C/O LINDE PLC
- **STREET 2:** FORGE, 43 CHURCH STREET WEST
- **CITY:** WOKING SURREY
- **PROVINCE COUNTRY:** X0
- **ZIP:** GU216HT
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LINDE PLC
- **CENTRAL INDEX KEY:** 0001707925
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL INORGANIC CHEMICALS [2810]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** FORGE, 43 CHURCH STREET WEST
- **CITY:** WOKING SURREY
- **STATE:** X0
- **ZIP:** GU216HT
- **BUSINESS PHONE:** 00441483242200

**MAIL ADDRESS:**
- **STREET 1:** FORGE, 43 CHURCH STREET WEST
- **CITY:** WOKING SURREY
- **STATE:** X0
- **ZIP:** GU216HT

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZAMALIGHT PLC
- **DATE OF NAME CHANGE:** 20170622

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PRAXAIR
- **DATE OF NAME CHANGE:** 20170614

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZAMALIGHT PLC
- **DATE OF NAME CHANGE:** 20170530

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Lamba Sanjiv<br><sub>(Last) (First) (Middle)</sub><br>C/O LINDE PLC<br>FORGE, 43 CHURCH STREET WEST<br><sub>(Street)</sub><br>WOKING SURREY, X0 GU216HT<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-12-08 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>LINDE PLC [ LIN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Ordinary Shares | 2025-12-08 |  | P |  | 2520 | A | 396.68<sup>(1)</sup> | 90794.191 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | $0 |  |  |  |  |  |  | <sup>(2)</sup> | <sup>(2)</sup> | Ordinary Shares | 6364 |  | 6364 | D |  |
| Restricted Stock Units | <sup>(3)</sup> |  |  |  |  |  |  | <sup>(3)</sup> | <sup>(3)</sup> | Ordinary Shares | 6405 |  | 6405 | D |  |
| Restricted Stock Units | <sup>(4)</sup> |  |  |  |  |  |  | <sup>(4)</sup> | <sup>(4)</sup> | Ordinary Shares | 7015 |  | 7015 | D |  |
| Stock Options (right to buy) | $468.77 |  |  |  |  |  |  | <sup>(5)</sup> | 2035-03-07 | Ordinary Shares | 44696 |  | 44696 | D |  |
| Stock Options (right to buy) | $465.29 |  |  |  |  |  |  | <sup>(6)</sup> | 2034-03-07 | Ordinary Shares | 41530 |  | 41530 | D |  |
| Stock Options (right to buy) | $354.14 |  |  |  |  |  |  | <sup>(7)</sup> | 2033-03-07 | Ordinary Shares | 46365 |  | 46365 | D |  |
| Stock Options (right to buy) | $270.99 |  |  |  |  |  |  | <sup>(8)</sup> | 2032-03-07 | Ordinary Shares | 54920 |  | 54920 | D |  |
| Stock Options (right to buy) | $253.68 |  |  |  |  |  |  | <sup>(9)</sup> | 2031-03-08 | Ordinary Shares | 40995 |  | 40995 | D |  |
| Stock Options (right to buy) | $173.13 |  |  |  |  |  |  | <sup>(10)</sup> | 2030-03-09 | Ordinary Shares | 37565 |  | 37565 | D |  |
| Stock Options (right to buy) | $176.63 |  |  |  |  |  |  | <sup>(11)</sup> | 2029-03-20 | Ordinary Shares | 15470 |  | 15470 | D |  |
| Deferred Stock Units | 0<sup>(12)</sup> |  |  |  |  |  |  | <sup>(13)</sup> | <sup>(13)</sup> | Ordinary Shares | 410.272 |  | 410.272 | D |  |

---

### Footnotes:

(1) The price reported is the weighted average purchase price. The purchase prices ranged from $396.39 to $397.00. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

(2) Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.

(3) Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

(4) Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

(5) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.

(6) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

(7) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

(8) This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

(9) This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

(10) This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

(11) This option vests over three years in three consecutive equal annual installments beginning March 20, 2020.

(12) Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

(13) Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.

**Signature:** Anthony M. Pepper as attorney-in-fact  
**Date:** 2025-12-08

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**